GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Arich Enterprise Co Ltd (ROCO:4173) » Definitions » Change In Payables And Accrued Expense

Arich Enterprise Co (ROCO:4173) Change In Payables And Accrued Expense : NT$0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Arich Enterprise Co Change In Payables And Accrued Expense?

Arich Enterprise Co's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was NT$0 Mil. It means Arich Enterprise Co's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Sep. 2024 .

Arich Enterprise Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was NT$0 Mil. It means Arich Enterprise Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .


Arich Enterprise Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Arich Enterprise Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arich Enterprise Co Change In Payables And Accrued Expense Chart

Arich Enterprise Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Arich Enterprise Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Arich Enterprise Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arich Enterprise Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Arich Enterprise Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Arich Enterprise Co Business Description

Traded in Other Exchanges
N/A
Address
No.880, Zhongzheng Road, 14F-5, Zhonghe District, Taipei, TWN, 235601
Arich Enterprise Co Ltd is a Taiwan-based company operating in the pharmaceutical industry. The company is engaged in providing medical sales promotion and logistics services. The company markets and sells pharmaceutical products. The company's services cover customers including medical centers, area hospitals, district hospitals, general practitioners, and key accounts which include chain stores and hypermarkets, drug stores, and wholesalers. The product portfolio of the company includes Actos, Aftach, Cytotec, Gaster, Prometin, Hicee, Lederscon, Alinamin, Nacid tab, Setoral, Sibutil, and many more.

Arich Enterprise Co Headlines

No Headlines